In recent years, some reports explored ddPCR based MRD targeting single nucleotide variants (SNVs) or translocation in leukemia like IDH2 variant in AML, NT5C2 and PRPS1 variant in ALL, BCR-ABL1 in ALL [24–27]. Here, IDH2 is linked to acute lymphoblastic leukemia.